Can we predict who will benefit from tic therapy? new study aims to find out

NCT ID NCT06270251

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 30 people aged 12 to 21 with chronic tic disorders as they go through 8 sessions of CBIT, a well-established behavioral therapy. Researchers will track tic severity, controllability, and other factors to see what predicts a good response. The goal is to understand why only about half of people improve with CBIT and to find ways to boost its effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Comprehensive Behavioral Intervention for Tics (CBIT)
What this could lead to
If this study succeeds, it could reveal why some people improve with CBIT and others don't, pointing toward ways to make the therapy more effective.
What could go wrong
This is a small, early-stage observational study with only 30 participants, so findings may not apply to everyone. It is not testing a new treatment, just watching how an existing one works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC TIC DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Minnesota

    RECRUITING

    Minneapolis, Minnesota, 55414, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.